Sponsor special: Up to $2,500 of FREE silver AND a FREE safe on qualifying orders - Call 855-862-3377 or text “AMERICAN” to 6-5-5-3-2

“Every regulator, every health authority, every government should be screaming from the top of their lungs: ‘This is a problem. This is a national [and] global crisis. We should look into it.’ But there’s silence on it, and I believe they’re silent because they know the answer.”

Edward Dowd was a Wall Street executive working as a growth portfolio manager for BlackRock. Utilizing his skills in recognizing fraud and interpreting statistics, he started compiling and analyzing data on injury and death associated with the COVID-19 genetic vaccines.

“We applied what we did in finance to what we’re seeing in the populations across the globe in disability. So, we’re just measuring using our statistical tools to figure out when trends change. We saw excess death trend up in ‘21 and ‘22 and ‘23, and disabilities just really take off in ‘21,” says Mr. Dowd.

He recently testified in the Senate about his findings, which are documented in his book, ‘“Cause Unknown:” The Epidemic of Sudden Deaths in 2021 & 2022.’

“If you look at the the stock prices of Pfizer and Moderna ... they’re at critical junctures in their technical stock prices,” says Mr. Dowd. “In fact, Pfizer, I think, is now below its pre-COVID price.”

How have the number of excess deaths and disabilities changed given the low booster uptake in America today? What about in other countries?

“The booster uptake in the U.S. is quite low now. So, the good news is there seems to be a declining trend in excess mortality—not [in] disability so much, unfortunately,” says Mr. Dowd.

Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.